Cargando…
Targeted inhibition of CX3CL1 limits podocytes ferroptosis to ameliorate cisplatin-induced acute kidney injury
BACKGROUND: It is widely acknowledged that cisplatin-induced nephrotoxicity hinders its efficacy during clinical therapy. Effective pharmaceutical interventions for cisplatin-induced acute kidney injury (Cis-AKI) are currently lacking. Prior studies have implicated the chemokine CX3CL1 in the develo...
Autores principales: | Gong, Qiming, Lai, Tengfang, Liang, Liudan, Jiang, Yan, Liu, Fahui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594885/ https://www.ncbi.nlm.nih.gov/pubmed/37875838 http://dx.doi.org/10.1186/s10020-023-00733-3 |
Ejemplares similares
-
CX3CL1 promotes cell sensitivity to ferroptosis and is associated with the tumor microenvironment in clear cell renal cell carcinoma
por: Gong, Qiming, et al.
Publicado: (2022) -
Twist1 in podocytes ameliorates podocyte injury and proteinuria by limiting CCL2-dependent macrophage infiltration
por: Ren, Jiafa, et al.
Publicado: (2021) -
Polydatin Attenuates Cisplatin-Induced Acute Kidney Injury by Inhibiting Ferroptosis
por: Zhou, Lu, et al.
Publicado: (2022) -
The deficiency of CX3CL1/CX3CR1 system ameliorates high fructose diet-induced kidney injury by regulating NF-κB pathways in CX3CR1-knock out mice
por: Yu, Yong-Wu, et al.
Publicado: (2018) -
Reduced glutathione ameliorates acute kidney injury by inhibiting ferroptosis
por: He, Leyu, et al.
Publicado: (2023)